u/cormac_danquah

Which phase and which arm are you quoting?

Continuous monitoring shows the shape: postprandial excursions, overnight behaviour and time in range. Two people with identical A1c can have very different distributions.

Are you quoting advice from before the compounded arrangements changed?

a1c can be affected by things that have nothing to do with glucose

A1c is a three-month average and it lags everything

do not import intuitions from the obesity programmes

independent testing on this compound is very thin

research material is not approved for human use, which is why the clinical record here is thin

Is this about registration or about subsidy?

My ferritin moved and it turned out to have nothing to do with glucose at all.

The diabetes and obesity programmes are separate, with different populations and different primary endpoints. Reading a result across from one to the other is not a comparison.

Incretin-based agents stimulate insulin secretion in a glucose-dependent manner, which is why hypoglycaemia risk with them alone is low. Risk rises with agents that act independently of glycaemia.

It is a dual agonist at the GLP-1 and glucagon receptors.

Adding the standing caveat — unapproved compound, research material is not for human use.

Severe, or unpleasant? They are genuinely different questions and the answers diverge.

Agreed. The failures are the part that is missing from every other board, which is why this one matters.

Kept fingersticks alongside the sensor for two weeks to sanity-check it. Worth doing once.

Bought small because the evidence base is early. That is the only defensible position I could construct.

Held the dose for an extra six weeks instead of stepping. The nausea settled and I lost the same amount anyway.

I would not treat one pharmacy’s quote as the national price. Variation between them is substantial.

Disagree — that is an obesity trial endpoint and this thread is about glycaemic control.

Constipation is mostly reduced intake plus reduced fluid, not a direct effect. That is why the boring fibre and water answer keeps working.

Personal importation provisions exist, are narrow, and carry conditions. Any summary of them here should be checked against the current official wording rather than a forum post.

That is an escalation schedule for an unapproved compound and this board does not host those.

Most of what gets posted here is procedural rather than dramatic: a step skipped, a document not requested, a temperature not considered, a pace chosen out of impatience.

Told everybody, then stopped, then had to tell everybody that too. That was harder than any of the rest of it.

sulphur burps are unpleasant and they are not dangerous

Same. The thing that went wrong for me was procedural and boring and it cost me a lot.

The three numbers, and what each one can and cannot tell you.

Disagreeing with this line: that endpoint is from the obesity programme and does not answer the question.

fatigue plus low intake is usually just low intake

the regret is usually about pace, not about the decision

do not import US advice into an Australian thread

Disagree. Severe abdominal pain is not on the list of things to wait out, and this board should not be treating it as one.

Lost money to a shop that had nothing verifiable on file anywhere. Posting so that somebody searching that name finds this.

metformin and an incretin agonist are not in competition

Yes. Holding the dose is a real option and it does not mean you have failed at anything.

Australia or New Zealand?

This is the shape almost everybody here describes, and it is the single most reassuring thing in the thread.

Disagreeing with this one line: that symptom is not on the wait-and-see list and should not be posted as though it is.

Disagree — that is an obesity trial endpoint and this thread is about glycaemic control.

Cosigning on the glucagon arm. It is the mechanistic thread that connects the hepatic and the metabolic effects.

Agreed that the published criteria are the authority.

Adding the quickest step — ask the pharmacist to check the wholesaler.